Preventive effect of hydrotalcite on gastric mucosal injury in rats induced by taurocholate

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1427-1430

  Yu, Bao Ping ^a   Sun, Jun ^a   Li, Mu Qi ^a   Luo, He Sheng ^a   Yu, Jie Ping ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROTALCITE; MESSENGER RNA; PROTEIN C FOS; RANITIDINE; TAUROCHOLIC ACID; TREFOIL FAMILY FACTOR 2; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZATION; RAT; STATISTICAL ANALYSIS; STOMACH MUCOSA; STOMACH MUCOSA INJURY; STOMACH PROTECTION;

EID: 0043066732     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1427     Document Type: Article

References (52)

1. Rankin BJ, Zhu H, Webb M, Roberts NB. The development and in-vitro evaluation of novel mixed metal hydroxy-carbonate compounds as phosphate binders. J Pharm Pharmacol 2001; 53: 361-369
2. Holtermuller KH, Liszkay M, Bernard I, Haase W. [Therapy of stomach ulcer-a comparison between the low dosage antacid hydrotalcite and ranitidine-results of a randomized multicenter double-blind study. Talcivent Study Group]. Z Gastroenterol 1992; 30: 717-721
3. Lambrecht N, Trautmann M, Korolkiewicz R, Liszky M, Peskar BM. Role of eicosanoids, nitric oxide, and afferent neurons in antacid induced protection in the rat stomach. Gut 1993; 34: 329-337
4. Schmassmann A, Tarnawski A, Gerber HA, Flogerzi B, Sanner M, Varga L, Halter F. Antacid provides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut 1994; 35: 896-904
5. Tarnawski AS, Tomikawa M, Ohta M, Sarfeh IJ. Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action. J Physiol Paris 2000; 94: 93-98
6. Dreyer M, Marwinski D, Wolf N, Dammann HG. [Acidity profile in humans after multiple oral administration of hydrotalcite]. Arzneimittel Forschung 1991; 41: 738-741
7. Vatier J, Ramdani A, Vitre MT, Mignon M. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers. Arzneimittel Forschung 1994; 44: 514-518
8. Simoneau G. Absence of rebound effect with calcium carbonate. Eur J Drug Metab Pharmacokinet 1996; 21: 351-357
9. Watters KJ, Murphy GM, Tomkin GH, Ashford JJ. An evaluation of the bile acid binding and antacid properties of hydrotalcite in hiatus hernia and peptic ulceration. Curr Med Res Opin 1979; 6: 85-87
10. Mendelsohn D, Mendelsohn L. Hydrogen ion, pepsin and bile acid binding properties of hydrotalcite. S Afr Med J 1975; 49: 1011-1014
11. Poulsom R. Trefoil peptides. Baillieres Clin Gastroenterol 1996; 10: 113-134
12. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract: Trefoil peptides. J Gastroenterol 2000;35 (Suppl 12): 69-74
13. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 1999; 103: R31-R38
14. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376-383
15. Al-Azzeh ED, Fegert P, Blin N, Gott P. Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta 2000; 1490: 324-332
16. Sommer P, Blin N, Gott P. Tracing the evolutionary origin of the TFF-domain, an ancient motif at mucous surfaces. Gene 1999; 236: 133-136
17. McKenzie C, Thim L, Parsons ME. Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat. Aliment Pharmacol Ther 2000; 14: 1033-1040
18. Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao CM, Podolsky DK, Wang TC. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002; 109: 193-204.
19. Tran CP, Cook GA, Yeomans ND, Thim L, Giraud AS. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 1999; 44: 636-642
20. Taupin D, Pedersen J, Familari M, Cook G, Yeomans N, Giraud AS. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 2001; 81: 397-408
21. Kawanaka H, Tomikawa M, Baatar D, Jones MK, Pai R, Szabo IL, Sugimachi K, Sarfeh IJ, Tarnawski AS. Despite activation of EGF-receptor-ERK signaling pathway, epithelial proliferation is impaired in portal hypertensive gastric mucosa: Relevance of MKP-1, c-fos, c-myc, and cyclin D1 expression. Life Sci 2001; 69: 3019-3033
22. Fu X, Gu X, Sun T. [mRNA and protein expression of three growth-related factors and their possible signal transduction pathways in wound healing] Zhonghua Waike Zazhi 2001; 39: 714-717
23. Schuligoi R, Herzeg G, Wachter C, Jocic M, Holzer P. Differential expression of c-fos messenger RNA in the rat spinal cord after mucosal and serosal irritation of the stomach. Neuroscience 1996; 72: 535-544
24. Polk WH Jr, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, Coffey RJ Jr. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992; 102: 1467-1474
25. Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136-138
26. Vatier J, Vitre MT, Lionnet F, Poitevin C, Mignon M. Assessment of antacid characteristics of drugs containing a combination of aluminium and magnesium salts using the "artificial stomach" model. Arzneimittel Forschung 1990; 40: 42-48
27. Kokot ZJ. Effect of pepsin on the kinetics of HCl neutralization by dihydroxyaluminum sodium carbonate, hydrotalcite and dihydroxyaluminum aminoacetate. Acta Pol Pharm 1991; 48: 27-31
28. Murphy MS. Growth factors and the gastrointestinal tract. Nutrition 1998; 14: 771-774
29. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. Gastrointestinal mucosal regeneration: Role of growth factors. Front Biosci 1999; 4: D303-D309
30. Hahm KB, Lee KM, Kim YB, Hong WS, Lee WH, Han SU, Kim MW, Ahn BO, Oh TY, Lee MH, Green J, Kim SJ. Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment Pharmacol Ther 2002; 16(Suppl 2): 115-127
31. Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, Kurata T, Sairenji T. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Virology 2001; 288: 109-118
32. Kanai M, Konda Y, Nakajima T, Izumi Y, Takeuchi T, Chiba T. TGF-alpha inhibits apoptosis of murine gastric pit cells through an NF-kappaB-dependent pathway. Gastroenterology 2001; 121: 56-67
33. Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, Stolte M, Bayerdorffer E, Malfertheiner P. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 2000; 82: 1795-1800
34. Kang B, Alderman BM, Nicoll AJ, Cook GA, Giraud AS. Effect of omeprazole-induced achlorhydria on trefoil peptide expression in the rat stomach. J Gastroenterol Hepatol 2001; 16: 1222-1227
35. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994; 94: 376-383
36. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, Thim L, Hanby AM. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995; 108: 108-116
37. Kato K, Chen MC, Nguyen M, Lehmann FS, Podolsky DK, Soll AH. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures. Am J Physiol 1999; 276: G1105-G1116
38. Goke MN, Cook JR, Kunert KS, Fini ME, Gipson IK, Podolsky DK. Trefoil peptides promote restitution of wounded corneal epithelial cells. Exp Cell Res 2001; 264: 337-344
39. Langer G, Walter S, Behrens-Baumann W, Hoffmann W. [TFF peptides. New mucus-associated secretory products of the conjunctiva.] Ophthalmologe 2001; 98: 976-979
40. Wright NA. Aspects of the biology of regeneration and repair in the human gastrointestinal tract. Philos Trans R Soc Lond B Biol Sci 1998; 353: 925-933
41. Poulsen SS, Thulesen J, Christensen L, Nexo E, Thim L. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 1999; 45: 516-522
42. Ogata H, Podolsky DK. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am J Physiol 1997; 273: G348-354
43. Chen L, Tong A, Yu D. [Effects of fluoride on the expression of c-fos and c-jun genes and cell proliferation of rat osteoblasts] Zhonghua Yufang Yixue Zazhi 2000; 34: 327-329
44. Di Toro R, Campana G, Murari G, Spampinato S. Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells. Eur J Pharm Sci 2000; 11: 291-298
45. Osaki M, Tsukazaki T, Yonekura A, Miyazaki Y, Iwasaki K, Shindo H, Yamashita S. Regulation of c-fos gene induction and mitogenic effect of transforming growth factor-beta1 in rat articular chondrocyte. Endocr J 1999; 46: 253-261
46. Li G, Wu D, Xiao B, Li J. Effect of lead on the expression of immediate early genes in different regions of rat brain. Weisheng Yanjiu 1999; 28: 65-69
47. Fu X, Jiang L, Sun T. The significance and characteristics of the gene expressions of c-fos and c-jun in hypertrophic scar and chronic ulcer tissues Zhonghua Shaoshang Zazhi 2000; 16: 300-302
48. Tarnawski AS, Pai R, Wang H, Tomikawa M. Translocation of MAP (Erk-1 and -2) kinases to cell nuclei and activation of c-fos gene during healing of experimental gastric ulcers. J Physiol Pharmacol 1998; 49: 479-488
49. Yanaka A, Suzuki H, Shibahara T, Matsui H, Nakahara A, Tanaka N. EGF promotes gastric mucosal restitution by activating Na(+)/H(+) exchange of epithelial cells. Am J Physiol Gastrointest Liver Physiol 2000; 282: G866-G876
50. Wong BC, Wang WP, So WH, Shin VY, Wong WM, Fung FM, Liu ES, Hiu WM, Lam SK, Cho CH. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment Pharmacol Ther 2001; 15: 1459-1465
51. Hsieh JS, Wang JY, Huang TJ. The role of epidermal growth factor in gastric epithelial proliferation in portal hypertensive rats exposed to stress. Hepatogastroenterology 1999; 46: 2807-2811
52. Miyazaki Y, Hiraoka S, Tsutsui S, Kitamura S, Shinomura Y, Matsuzawa Y. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Gastroenterology 2001; 120: 108-116